T. Ott

发表

Structural Requirements of Transmembrane Domain 3 for Activation by the M1 Muscarinic Receptor Agonists AC-42, AC-260584, Clozapine, and N-Desmethylclozapine: Evidence for Three Distinct Modes of Receptor Activation

M. Brann, T. Spalding, Jian-Nong Ma, 2006, Molecular Pharmacology.

Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.

F. Piu, K. Mcfarland, E. Currier, 2009, Journal of medicinal chemistry.

A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells.

R. Struthers, F. Lio, Sarah C Hudson, 2005, Journal of pharmacological and toxicological methods.

The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.

N. Ling, Xin-jun Liu, R. Struthers, 2006, Biochemical and biophysical research communications.

A novel mammalian receptor for the evolutionarily conserved type II GnRH

Adam J Pawson, Stuart Maudsley, M. Millar, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Receptor activation in GNRH receptors

T. Ott, 2000 .

A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12.

Adam J Pawson, K. Morgan, D. Conklin, 2003, Endocrinology.

Characterization of the Mas‐related gene family: structural and functional conservation of human and rhesus MrgX receptors

M. Brann, N. Nash, E. Burstein, 2006, British journal of pharmacology.

Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonist.

N. Illing, R. Millar, C. Flanagan, 2002, Molecular endocrinology.

A Chicken Gonadotropin-releasing Hormone Receptor That Confers Agonist Activity to Mammalian Antagonists

S. Sealfon, N. Illing, R. Millar, 2001, The Journal of Biological Chemistry.

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

K. Mcfarland, D. Bonhaus, J. Lameh, 2010, Neuropharmacology.

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Ethan S. Burstein, Fabrice Piu, Mark R. Brann, 2006, Journal of Pharmacology and Experimental Therapeutics.

Identification of CC Chemokine Receptor 7 Residues Important for Receptor Activation*

S. Nickolls, R. Struthers, A. Pahuja, 2004, Journal of Biological Chemistry.

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

K. Mcfarland, D. Bonhaus, J. Lameh, 2010, Neuropharmacology.

Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).

N. Ling, R. Struthers, F. Lio, 2004, Biochemistry.